Startups
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Summary
39
Industry
Total funding Amount
$180M
Fundraising History
-
Jan 01 '21 Series B$150M
-
May 01 '20 Unknown$8.8M
Investors
-
EIR VenturesSeries B
-
Novo A/SUnknown